Calcifediol
For Laboratory Research Only. Not for Clinical or Personal Use.
- Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
- Dry Ice Shipment: No


Calcifediol
UNSPSC Description:
Calcifediol (25-hydroxy Vitamin D3) is an effective VDR ligand and VD supplement. Calcifediol is a prohormone of the vitamin D endocrine system (VDES) and is hydroxylated in the liver to produce the active form, calcitriol. Calcifediol can rapidly increase serum VD levels[1][2][3].Target Antigen:
Endogenous Metabolite; VD/VDRType:
Natural ProductsRelated Pathways:
Metabolic Enzyme/Protease;Vitamin D Related/Nuclear ReceptorApplications:
Metabolism-sugar/lipid metabolismField of Research:
Metabolic DiseaseAssay Protocol:
https://www.medchemexpress.com/Calcifediol.htmlPurity:
99.94Solubility:
DMSO : ≥ 100 mg/mLSmiles:
C=C(CC1)/C(C[C@H]1O)=C\C=C2[C@@]3([H])[C@@](CCC\2)(C)[C@@H]([C@H](C)CCCC(C)(C)O)CC3Molecular Weight:
400.64References & Citations:
[1]Castoldi A, et al. Calcifediol-loaded liposomes for local treatment of pulmonary bacterial infections. Eur J Pharm Biopharm. 2016 Nov 22.|[2]Wei Zheng, et al. Vitamin D-induced vitamin D receptor expression induces tamoxifen sensitivity in MCF-7 stem cells via suppression of Wnt/β-catenin signaling. Biosci Rep. 2018 Dec 7;38(6):BSR20180595.Front Pharmacol. 2020 Mar 31;11:200.|Int Immunopharmacol. 2023 Jun 30;122:110558.|Int J Mol Sci. 2017 Dec 19;18(12). pii: E2764.|Nat Chem Biol. 2022 Aug 18.|Proc Natl Acad Sci U S A. 2022 Apr 12;119(15):e2117004119.|Ther Adv Endocrinol. 2020 Oct 20. |Virol Sin. 2024 Aug 19:S1995-820X(24)00134-2.|Sci Rep. 2022 Feb 22;12(1):3014.Shipping Conditions:
Blue IceStorage Conditions:
-20°C, 3 years (Powder)Clinical Information:
LaunchedCAS Number:
19356-17-3